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Probiotic supplements containing living bacteria have attracted interest as a potential source of health benefits for 
humans and livestock. The aim of this study was to determine whether administration of Lactobacillus acidophilus 
strain L-55 (LaL-55) enhances the immune response among chicks exposed to a Newcastle disease virus (NDV)-
based live attenuated vaccine. Oral administration of LaL-55 augmented the elevation in the total numbers of 
leukocytes and lymphocytes following inoculation with the NDV-based live attenuated vaccine. Monocyte counts 
increased after LaL-55 administration independent of inoculation with the NDV vaccine. Among chicks that were 
administered LaL-55, there was a dose-dependent increase in the NK cell activity measured by a 51Cr release 
assay at 2 weeks after the secondary NDV vaccine inoculation. Two weeks after the secondary inoculation with 
the NDV vaccine, interferon (IFN)-γ-mRNA expression was significantly elevated in mononuclear splenocytes 
from chicks that were administered LaL-55. Meanwhile, LaL-55 administration did not change the mRNA levels 
of IFN-α, IFN-β, and interleukin-1β. These results may suggest that coadministration of LaL-55 with an NDV 
vaccine augments the immune response against the virus. Therefore, LaL-55 may help protect against viral 
diseases in poultry.
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INTRODUCTION
Various pathogens, such as highly pathogenic strains of 
influenza and porcine fever, have become major threats to public 
health and livestock suppliers around the world. Furthermore, 
excessive use of antibiotics among humans and livestock has 
promoted the emergence of antibiotic-resistant organisms, which 
are rapidly spreading and causing problems for public health. 
Along with the production of drugs and vaccines, probiotics 
are being considered as additional tools for the prevention and 
treatment of diseases. Live bacteria supplements have recently 
become widely used, and probiotics have become an important 
target for providing health benefits in humans and animals.
Lactic acid bacteria (LAB), including members of the genera 
Lactobacillus and Bifidobacterium, are normal inhabitants of 
the gastrointestinal tract that are classified as probiotic bacteria. 
Several studies in mammals have reported the benefits of 
intestinal bacteria, especially LAB. Some of the benefits provided 
by LAB include the production of various nutrients for the host, 
prevention of infections caused by intestinal pathogens, and 
modulation of the normal immune response [1]. However, there 
is only a small number of published reports demonstrating the 
benefits of probiotic bacteria on the avian immune system. The 
effects of probiotics against viral infection in avian species have 
not yet been investigated. Lactobacillus spp. are the main type 
of LAB used in probiotic formulations because they possess 
potentially advantageous properties [2]. In addition, Lactobacillus 
acidophilus has been proven to elevate immunological activity by 
stimulating both the innate and adaptive immune responses [3–5]. 
In vitro studies have indicated that L. acidophilus is a strong 
inducer of T helper type 1 (Th1) cytokines, including interleukin 
(IL)-12 and interferon (IFN)-γ [6, 7]. Also, L. acidophilus is 
involved in enhancement of the activity of NK cells [8]. Clinical 
trials involving oral administration of L. acidophilus strain L-55 
(LaL-55) show that this strain effectively suppresses experimental 
allergic rhinitis [8] and experimental atopic dermatitis in mice 
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[9]. Therefore, L. acidophilus, specifically LaL-55, was selected 
for this study to determine whether it may help protect chickens 
against infectious diseases by boosting immune function. The 
aim of this study was to evaluate the immunomodulatory and 
beneficial effects of LaL-55 administration in chicks inoculated 
with a live attenuated Newcastle disease virus (NDV) vaccine.
The attenuated NDV vaccine used in this study was a 
lyophilized version of an attenuated NDV clone 30 injected into 
a growing chicken egg. Live and inactivated NDV vaccines have 
been widely used. Live vaccines based on lentogenic strains are 
widely used because of their high efficacy and availability [10]. 
Inactivated oily vaccines are used for enhancing and sustaining 
immunity [10, 11]. Vaccines are commonly administered by 
the eye- or nose-drop method. Generally, cellular immunity 
is crucial in viral infection because the viral pathogenesis 
includes an intracellular phase. It is important to understand 
this response, and therefore estimation of the cellular immunity 
against a viral infection such as NDV should be aligned with 
estimation of the humoral antibody response. Cell-mediated 
immune response is essential for virus clearance and may be a 
key player in vaccinal immunity to NDV [12]. Lambrecht et al. 
have reported the presence of antigen-specific chicken IFN-γ 
production as an indicator of actively acquired immunity to NDV 
[13]. Furthermore, cell-mediated immune response was detected 
in the spleens of chickens vaccinated twice or vaccinated and 
challenged with wild-type virus [14]. The data obtained from this 
study are also expected to provide useful information for future 
probiotic formulations, which may help control the spread of 
infectious diseases in chickens.
MATERIALS AND METHODS
Animals
Male chicks (White Leghorn Julia strain, newborn chicks) 
were purchased from Akebono Noen (Ehime, Japan). Chicks 
ingested feed and water ad libitum. Animal care and experiments 
were carried out in accordance with the guidelines for animal 
experiments at Okayama University. The animals were housed at 
a constant temperature (27 ± 1°C) with a 12 hr dark/light cycle. 
All procedures were conducted in accordance with the Policy 
on the Care and Use of the Laboratory Animals at Okayama 
University. The body weights of chicks were measured daily 
during this experiment.
Administration of L. acidophilus L-55 and NDV vaccine 
inoculation
Freeze-dried powder of LaL-55 was prepared as previously 
reported [8]. Chicks (n=24) were randomly divided into four 
groups and were maintained on different concentrations of freeze-
dried LaL-55 (high-dose group, 0.5 mg/100 g body weight; 
middle-dose group, 0.15 mg/100 g body weight; low-dose group, 
0.05 mg/100 g body weight; and control group, 0 mg/100 g 
body weight). Each volume of freeze-dried LaL-55 powder 
was suspended in 1 mL of distilled water and compulsively 
administered orally to chicks daily from 1 to 6 weeks of age. 
Identical volumes of distilled water were administered to chicks 
in the control group.
The live attenuated NDV vaccine (10 µL; ND clone 30, 
Intervet, Osaka, Japan) was dropped into the eye and nose at 
2 weeks of age (primary inoculation). The same dose of NDV 
vaccine was administered at the same site in 4-week-old chicks in 
all treatment groups (the secondary inoculation).
Peripheral blood cell counts
Heparinized blood samples were collected from a wing 
vein on a weekly basis from 2 weeks of age (before primary 
inoculation with the NDV vaccine) to 6 weeks of age (2 weeks 
after secondary inoculation with the NDV vaccine). To determine 
the total number of leukocytes, lymphocytes, monocytes, and 
granulocytes, peripheral blood samples from each treatment 
group were stained with Natt and Herrick staining solution. Cells 
were counted using a hemocytometer [15].
Cytolytic activity of mononuclear cells
Mononuclear cells were harvested from the small intestine 
using the following protocol: briefly, chicks were euthanized 
at the end of the experiment (6 weeks of age, 2 weeks after 
secondary inoculation), and a portion of the small intestine (5 cm 
upper from the base of the cecum, approximately 10 cm long) 
was collected. A portion of the mucosa from the small intestine 
was collected in RPMI 1640 medium (Nissui Pharmaceutical, 
Osaka, Japan). After stirring sufficiently to disperse and wash 
cells, mononuclear cells in the mucosa were isolated using 
mononuclear cell separation medium (Ficoll-Paque, Amersham, 
Uppsala, Sweden). The collected cells were washed three times 
and resuspended in RPMI 1640 medium at a density of 5 × 107 
cells/mL. A sample of the liver was collected from a Wistar 
rat that was anesthetized with ether. Liver cells were dispersed 
by cutting the liver with scissors and homogenizing the tissue 
fragment using a 25G needle and syringe. The cells were washed 
three times and resuspended in RPMI 1640 medium at a density 
of to 1 × 106 cells/0.7 mL. Chromium-51 (51Cr; PerkinElmer 
Inc., Waltham, MA, USA) solution (0.3 mL) prepared to 3.7 × 
104 Bq/mL was added to 0.7 mL of the target cell suspension. 
The mixture was incubated for 1 hr at room temperature under 
mild shaking conditions. The cells were washed and resuspended 
in RPMI 1640 medium at a density of 1 × 106 cells/mL. The 
effector cell suspension (100 µL) and the same volume of 
target cell suspension were added to a 96-well microplate. The 
cell suspensions were incubated in a CO2 incubator (5% CO2) 
at 37°C for 2 hr. After incubation and centrifugation, the γ-ray 
count of the supernatant was measured using a γ-counter (count 
A). The cytolytic activity of effector cells was calculated using 
count A, the count obtained under the condition of spontaneous 
51Cr release from target cells, and the count obtained under the 
condition of 100% 51Cr release from target cells treated with 3% 
sodium lauryl sulfate (Nacalai Tesque, Inc., Kyoto, Japan). The 
cytolytic activity was expressed as a percentage.
Semiquantitative RT-PCR
The levels of mRNA for pro-inflammatory cytokines (IFN-α, 
IFN-β, IFN-γ, IL-1β) were measured using semiquantitative RT-
PCR. The sequences for the primer pairs used in this experiment 
are listed in Table 1 [16–19]. The chicks were euthanized at the 
end of the experiment (6 weeks of age, 2 weeks after secondary 
inoculation), and spleen tissue was collected. Mononuclear 
splenocytes were isolated using mononuclear cell separation 
medium (Ficoll-Paque; Amersham Bioscience, Uppsala, Sweden). 
Collected cells were washed three times and resuspended in 
RPMI-1640 medium (Nissui Pharmaceutical, Tokyo, Japan) to 
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a density of 5 × 106 cells/mL. The cells were preserved in an 
RNA stabilizing agent (Ambion, Austin, TX, USA) at −20°C 
until ready for use. RNA extraction was performed using TRIzol 
reagent (Invitrogen, Carlsbad, CA, USA). The extracted RNA 
was treated with DNase I (Takara Bio, Otsu, Shiga, Japan), 
and cDNA synthesis was carried out using oligo dT15. The 
PCR cycling conditions were as follows: denaturation at 95°C 
for 1 min, annealing for 1 min at the annealing temperature 
for each primer set, elongation at 72°C for 30 sec, and a single 
extension step for 5 min at 72°C. β-actin amplification was 
carried out over 22 cycles and used as a positive control. The 
amplification products were visualized using an agarose gel and 
ethidium bromide staining. The intensity of the amplified target 
fragments was quantified using the ImageJ 1.42q software (NIH, 
Bethesda, MD, USA). The relative expression of each cytokine 
was calculated by dividing the band intensity for each cytokine 
by the corresponding β-actin intensity.
Statistical analysis
Data represent the mean ± SE of the samples (n=6 in each 
experimental group). Statistical analyses were carried out using 
Student’s t-test. Statistical significance was determined by p<0.05.
RESULTS
Leukocyte counts
Total leukocyte counts in the peripheral blood of chicks 
increased 1 week after the primary and secondary inoculations 
with the NDV vaccine (Fig. 1a). The leukocyte count in the 
high-dose group at 1 week after the primary inoculation (3 weeks 
old in Fig. 1a) was significantly higher than the average count in 
the control group (p<0.05). The counts in the three groups that 
received LaL-55 were significantly higher than that in the control 
group at 1 week after the secondary NDV inoculation (5 weeks 
old in Fig. 1a, p<0.05). Lymphocyte counts in the peripheral 
blood of both the low-dose and high-dose chick groups were 
significantly higher than that of the control group (p<0.05) at 
1 week after the second inoculation with the NDV vaccine (5 
weeks old in Fig. 1b). The lymphocyte count of the middle-dose 
group was significantly higher than that of the control at 2 weeks 
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Table 1. Primer sets for semiquantitative RT-PCR
Gene name Primer sequence (5´-3´) Annealing temperature (oC) References
IFN-γ Forward: AATGACTTGCCAGACTTACAAACTTG 69.0 [16]
Reverse: TTAGCAATTGCATCTCCTCTGAGACTGG
IFN-α Forward: GGGTACGACATCCTGTTGCTC 68.8 [17]
Reverse: CGGCTGATCCGGTTGAGGAG
IFN-β Forward: GCCACAGCCTCCTCAACCAGAT 69.5 [17]
Reverse: CAACGTCCCAGGTACAAGCACT
IL-1β Forward: TGAGGCTCAATTGCGCTGTA 62.1 [18]
Reverse: TGTCCAGGCGGTAGAAGATAGGA
β-actin Forward: TCTGGCACCACACTTTCTACAA 58.0 [19]
Reverse: CACAGGACTCCATACCCAAGA
Fig. 1. The course of leukocyte (a) or lymphocyte (b) counts in the peripheral blood of chicks that received the Newcastle disease virus 
(NDV) vaccine and oral LaL-55. Chickens were divided into four groups (n=6) and were maintained on different concentrations of 
freeze-dried LaL-55 (high-dose group, 0.5 mg/100 g body weight; middle-dose group, 0.15 mg/100 g body weight; low-dose group, 
0.05 mg/100 g body weight; and control group, 0 mg/100 g body weight). Heparinized blood samples were collected every week from 2 
weeks of age (before the primary NDV vaccine inoculation) to 6 weeks of age (2 weeks after the secondary inoculation). Representative 
data from three independent experiments are shown. *p<0.05 vs. control. Error bars represent the SE.
D. T. Ho, et al. 120
doi: 10.12938/bmfh.2019-033
after the second inoculation (6 weeks old in Fig. 1b, p<0.05). 
Monocyte counts tended to be higher in groups that received 
LaL-55, and the monocyte count of the middle-dose group was 
significantly higher than that of the control at 5 weeks of age. 
Monocyte counts did not change following inoculation with the 
NDV vaccine. Granulocyte counts were not significantly different 
among the treatment groups (data not shown).
Cytolytic activity
LaL-55 administration increased the cytolytic activity of 
mononuclear cells from the intestinal mucosa in a dose-dependent 
manner (Fig. 2). The cytolytic activity of mononuclear cells in the 
high-dose group (25.0 ± 2.3%) was significantly higher (p<0.01) 
than the cytolytic activities of cells in the control (10.3 ± 2.9%) 
and low-dose groups (12.8 ± 1.7%; Fig. 2).
Cytokine expression
Levels of IFN-γ mRNA were increased in a dose-dependent 
manner after oral administration of LaL-55. IFN-γ expression was 
significantly higher in the middle- and high-dose groups (p<0.01) 
than that in the control group (Fig. 3a). The mRNA levels of 
IL-1β, IFN-α, and IFN-β did not change after administration of 
LaL-55 (Fig. 3b–3d).
DISCUSSION
Various strategies, including vaccination, have been used to 
combat pathogenic organisms. However, due to the excessive 
use of antibiotics among humans and livestock and changes 
in the environment, antibiotic-resistant organisms and some 
pathogens have posed a huge problem for public health. In 
parallel with the production of drugs and vaccines, probiotics 
are being considered as an additional effective method for 
disease prevention and treatment. Recently, live or dead bacteria 
have been used to enhance the efficacy of vaccines. Probiotic 
bacteria have become a target of interest for promoting health 
benefits in humans and animals. LAB enhance vaccine efficacy 
by stimulating both the innate and adaptive immune responses 
[3–5]. In this study, we focused on LaL-55 and determined 
its beneficial effects on vaccine-administered animals. Some 
researchers have also reported that oral administration of LaL-55 
induced immunosuppressive effects against experimental allergic 
rhinitis and experimental atopic dermatitis [8, 9]. Hence, LaL-55 
has been expected to promote beneficial effects on the immune 
system of the chicken.
Differential white blood cell counts are important for detecting 
active infection by viruses and bacteria. The results of this 
study indicated that total and individual lymphocyte counts 
in the peripheral blood were increased by all doses of LaL-55 
after inoculation with the live attenuated NDV vaccine. It has 
been reported that the number of lymphocytes was increased 
by L. acidophilus administration in mice and chicken [1, 2, 6, 
9]. Few studies have shown the effects of a probiotic on either 
differential or total leukocyte counts [20–22]. A previous report 
also showed that the administration of lactobacilli augmented the 
proliferation of lymphocytes depending upon the dose and strain 
of the bacteria [23]. Administration of L. acidophilus has been 
shown to affect T cell populations in the blood and lymphoid 
organs of chickens [2, 9]. In this study, we did not clarify the 
composition of lymphocytes after LaL-55 administration in detail. 
However, the more prominent effects of LaL-55 administration 
on lymphocyte counts that were observed during the secondary 
response compared with the primary response indicate that LaL-
55 may affect the memory mechanisms of the immune system. 
The elevation of clonal expansion of lymphocytes responsible 
for eliminating NDV after exposure to attenuated NDV indicates 
that oral administration of LaL-55 may reinforce the resistance 
to other viruses, such as avian influenza, through the expansion 
of corresponding lymphocyte clones. Elevated numbers of 
monocytes in the peripheral blood of LaL-55-administered 
chicks show that the elimination of antigens by phagocytosis and 
antigen-presenting activity are consequentially elevated following 
LaL-55 administration. However, it is necessary to conduct more 
experiments to determine how LaL-55 affects the total numbers 
and composition of lymphocytes.
In the present study, the cytolytic activity of intestinal mucosal 
mononuclear cells was measured at 2 hr after the addition 
of target cells. NK cells are part of the innate immune system 
and are known to secrete cytokines and kill tumor cells or cells 
infected with viruses. Therefore, NK cells protect the host from 
pathogens through targeted elimination. The 51Cr release assay 
(CRA) is a standard method for measuring the cytotoxic effects 
of NK cells and the activity of cytolytic T lymphocytes [24–28]. 
Antigen-specific cell lysis exerted by CTLs begins after 2–3 
days of exposure to the antigen. Therefore, the cytolytic activity 
measured in this study is due to NK cells. The results of the 
present study indicate that oral administration of LaL-55 elevates 
the activity of NK cells in the intestinal mucosa. Previous studies 
have also reported that L. casei Shirota and a heat-killed strain 
of L. acidophilus La205 enhance the activity of NK cells in the 
peripheral blood [29, 30]. The enhanced activity of NK cells 
was previously explained to be due to the interaction between 
dendritic cells (DCs) and LAB [31]. In vitro studies have also 
indicated that L. acidophilus enhances NK cell activity [30].
LAB stimulate the production of IL-12 by DCs, which increases 
the IFN-γ production, activation, and cytotoxic activity of NK 
cells [32]. In our study, we also observed the upregulation of 
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Fig. 2. Effect of LaL-55 administration on cytolytic activity of 
mononuclear cells. Mononuclear cells were collected from the 
intestinal mucosa. Birds (n=6) were inoculated with the live 
attenuated Newcastle disease virus (NDV) vaccine at 2 weeks of 
age. Two weeks later (4 weeks of age), chicks were inoculated a 
second time with the NDV vaccine. Representative data from three 
independent experiments are shown. **p<0.01 vs. control. Error 
bars represent the SE.
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IFN-γ mRNA in the mononuclear cells from the middle- and high-
dose groups; this upregulation of IFN-γ may explain the enhanced 
activity of the NK cells. In addition, our results showed that the 
total number of monocytes in the peripheral blood increased after 
LaL-55 administration, but the expression of IL-1β mRNA did 
not change. This may suggest that LaL-55 administration affects 
DCs, but not macrophage function. However, it is necessary to 
confirm this by studying the effects of LaL-55 administration on 
DC activity and DC-mediated production of IL-12 in chicks. In 
vitro studies have indicated that L. acidophilus is a strong inducer 
of Th1 cytokines, including IL-12 and IFN-γ [6, 7]. The data 
in this study show that IFN-γ mRNA expression in the splenic 
mononuclear cells was upregulated following oral administration 
of the middle or high dose of LaL-55 at 2 weeks after secondary 
immunization with the NDV vaccine. By contrast, the mRNA 
levels of type I interferons (IFN-α and IFN-β) and IL-1β did not 
change. IFN-γ, which is produced by Th1, CTL, and NK cells, 
is involved in macrophage activation, Th1 differentiation, B cell 
differentiation, and NK cell activation. In the present study, it is 
not clear which type of cells upregulated IFN-γ mRNA, since the 
spleen contains all of the previously mentioned types of cells. 
However, it is possible to assume that IFN-γ production is related 
to the enhanced activity of NK cells and Th1 cells. The elevation 
of IFN-γ mRNA levels has been shown in studies related to 
the effect of LAB on the Th1/Th2 balance. Administration of 
other strains of LAB (L. brevis, L. acidophilus) increases the 
production of Th1 cell‐specific cytokines (IFN‐γ and IL-12) [23, 
33]. Our data support these previous findings, although we used 
a different strain of Lactobacillus. Takeda et al. reported that oral 
administration of killed LAB augments the production of IFN-α 
in the bronchoalveolar lavage fluid of mice [29]. In the present 
study, LaL-55 administration did not alter type I interferon gene 
expression in splenocytes. This discrepancy may be caused by 
differences in the cell types and LAB species used in these studies.
Overall, LaL-55 enhances the immune response following 
administration of a live attenuated NDV vaccine by increasing 
the number of leukocytes in the peripheral blood, augmenting NK 
cell activity, and increasing IFN-γ expression. Therefore, LaL-55 
could be used as a tool to enhance the immune response against 
viral infection in avian species.
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